Mitazalimab, a Potent CD40 Agonist in Combination with FOLFIRINOX Demonstrates Changes Consistent with Increased Immune Activation in TME and Peripheral Blood in a Preclinical Pancreatic Cancer Tumor Model
Cancer Research（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要